Open trial of fluoxetine in children and adolescents with dysthymic disorder or double depression. (Q53916498)

22 May 2018

title

Open trial of fluoxetine in children and adolescents with dysthymic disorder or double depression. (English)

1 reference

22 May 2018

0 references

1 reference

1 reference

3

L L Greenhill

1 reference

22 May 2018

author name string

B D Waslick

1

1 reference

22 May 2018

B T Walsh

2

1 reference

22 May 2018

M Eilenberg

4

1 reference

22 May 2018

L Capasso

5

1 reference

22 May 2018

D Lieber

6

1 reference

22 May 2018

publication date

1 December 1999

1 reference

22 May 2018

Journal of Affective Disorders

published in

1 reference

22 May 2018

volume

56

1 reference

22 May 2018

issue

2-3

1 reference

22 May 2018

page(s)

227-236

1 reference

22 May 2018

An Inventory for Measuring Depression

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

Major depressive disorder and dysthymia in young adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

The early--late onset distinction in DSM-III-R dysthymia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

Depressive disorders in childhood. I. A longitudinal prospective study of characteristics and recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

Depressive disorders in childhood. II. A longitudinal study of the risk for a subsequent major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

Depressive disorders in childhood III. A longitudinal study of comorbidity with and risk for conduct disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

Depressive disorders in childhood. IV. A longitudinal study of comorbidity with and risk for anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

Childhood-onset dysthymic disorder. Clinical features and prospective naturalistic outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

Pharmacological therapy of dysthymia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

A children's global assessment scale (CGAS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

Uncommon troubles in young people: prevalence estimates of selected psychiatric disorders in a nonreferred adolescent population

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

Rating weight loss on the Hamilton Depression Rating Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900032-4

7 January 2021

10.1016/S0165-0327(99)00032-4

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018